Preconception leukocyte telomere length and pregnancy outcomes among women with demonstrated fecundity.
telomere / fertility / reproductive aging / biologic aging / pregnancy loss / fecundity
Journal
Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199
Informations de publication
Date de publication:
18 11 2021
18 11 2021
Historique:
received:
03
05
2021
revised:
10
08
2021
pubmed:
4
9
2021
medline:
3
3
2022
entrez:
3
9
2021
Statut:
ppublish
Résumé
Is preconception leukocyte telomere length associated with fecundability, pregnancy loss and live birth among women attempting natural conception with a history of 1-2 prior pregnancy losses? Preconception leukocyte telomere length is not associated with fecundability, pregnancy loss or live birth. As women increasingly delay childbearing, accessible preconception biomarkers to predict pregnancy outcomes among women seeking natural conception could improve preconception counseling. Findings of small case-control or cross-sectional studies suggest that telomere attrition is associated with adverse pregnancy outcomes among women undergoing fertility treatment, but prospective studies in non-clinical populations are lacking. Participants included 1228 women aged 18-40 years with a history of 1-2 prior pregnancy losses who were recruited at four university medical centers (2006-2012). Preconception leukocyte telomere length was measured at baseline using PCR and reported as a ratio (T/S) in relation to population-specific standard reference DNA. Women were followed for up to six cycles while attempting to conceive. Associations of telomere length with fecundability, live birth and pregnancy loss were estimated using discrete Cox proportional hazards models and log-binomial models. After adjustment for age, BMI, smoking and other factors, preconception telomere length was not associated with fecundability (Q4 vs Q1 FOR = 1.00; 95% CI = 0.79, 1.27), live birth (Q4 vs Q1 RR = 1.00; 95% CI = 0.85, 1.19), or pregnancy loss (Q4 vs Q1 RR = 1.12; 95% CI = 0.78, 1.62). Telomere length was measured in leukocytes, which is an accessible tissue in women attempting natural conception but may not reflect telomere length in oocytes. Most women were younger than 35 years, limiting our ability to evaluate associations among older women. Participants had a history of 1-2 prior pregnancy losses; therefore, our findings may not be widely generalizable. Despite prior research suggesting that telomere length may be associated with pregnancy outcomes among women seeking fertility treatment, our findings suggest that leukocyte telomere length is not a suitable biomarker of pregnancy establishment or maintenance among women attempting natural conception. This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (National Institutes of Health, Bethesda, MD, USA; contract numbers HHSN267200603423, HHSN267200603424 and HHSN267200603426). The authors have no conflicts of interest to disclose. The trial was registered with ClinicalTrials.gov, number NCT00467363.
Identifiants
pubmed: 34477845
pii: 6363634
doi: 10.1093/humrep/deab201
pmc: PMC8600655
doi:
Banques de données
ClinicalTrials.gov
['NCT00467363']
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3122-3130Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology 2021. This work is written by US Government employees and is in the public domain in the US.
Références
Am J Obstet Gynecol. 2010 May;202(5):413-9
pubmed: 20207341
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):815-9
pubmed: 17416776
Am J Epidemiol. 2013 Jun 1;177(11):1271-8
pubmed: 23558353
Am J Obstet Gynecol. 2005 Apr;192(4):1256-60; discussion 1260-1
pubmed: 15846215
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Fertil Steril. 2016 Apr;105(4):946-952.e2
pubmed: 26707905
Fertil Steril. 2015 Feb;103(2):554-59.e1
pubmed: 25487749
Curr Opin Obstet Gynecol. 2006 Jun;18(3):280-5
pubmed: 16735827
Hum Genet. 1991 Nov;88(1):64-70
pubmed: 1959927
Reproduction. 2014 Apr 08;147(5):649-57
pubmed: 24472817
Hum Reprod. 2013 Apr;28(4):929-36
pubmed: 23377770
Obstet Gynecol. 2004 Jan;103(1):51-6
pubmed: 14704244
Hum Reprod. 2018 Apr 1;33(4):736-744
pubmed: 29452389
Cell Mol Life Sci. 2007 Jan;64(2):139-43
pubmed: 17219022
J Assist Reprod Genet. 2015 Nov;32(11):1697-703
pubmed: 26438644
Fertil Steril. 2020 Dec;114(6):1172-1173
pubmed: 33280724
N Engl J Med. 1982 Feb 18;306(7):424-6
pubmed: 7057834
Epidemiology. 2014 Jan;25(1):139-46
pubmed: 24213145
Obstet Gynecol Clin North Am. 2011 Sep;38(3):425-40
pubmed: 21961711
Aging Cell. 2002 Oct;1(1):40-6
pubmed: 12882352
Aging Cell. 2009 Jun;8(3):251-7
pubmed: 19302371
Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):28-34
pubmed: 21102320
Hum Reprod Update. 2002 Mar-Apr;8(2):141-54
pubmed: 12099629
Fertil Steril. 2020 Jan;113(1):217-223
pubmed: 31594634
J Assist Reprod Genet. 2009 Jul;26(7):383-9
pubmed: 19768530
JAMA. 2015 Dec 22-29;314(24):2654-2662
pubmed: 26717030
JAMA. 2017 Oct 10;318(14):1367-1376
pubmed: 29049585
Trends Endocrinol Metab. 2007 Mar;18(2):58-65
pubmed: 17275321
PLoS One. 2016 Jan 05;11(1):e0146424
pubmed: 26731744
Lancet. 2014 Jul 5;384(9937):29-36
pubmed: 24702835
J Assist Reprod Genet. 2013 Jun;30(6):793-8
pubmed: 23608779
Exp Gerontol. 2005 Jun;40(6):466-72
pubmed: 15963673
Fertil Steril. 2021 Apr;115(4):957-965
pubmed: 33272640
J Clin Endocrinol Metab. 2015 Nov;100(11):4215-21
pubmed: 26406293
Paediatr Perinat Epidemiol. 2013 Nov;27(6):598-609
pubmed: 24118062
BMC Med Res Methodol. 2008 Oct 30;8:70
pubmed: 18973665
Aging (Albany NY). 2018 Dec 8;10(12):3761-3773
pubmed: 30530921
Hum Reprod. 2009 May;24(5):1206-11
pubmed: 19202142